Cassette vectors for conversion of fab fragments into full-length human IgG1 monoclonal antibodies by expression in stably transformed insect cells

Hybridoma and Hybridomics

Volumn 22, Issue 3, 2003, Pages 135-145

  Guttieri, Mary C ^a   Sinha, Tanima ^a   Bookwalter, Carol ^a,b   Liang, Mifang ^a,c   Schmaljohn, Connie S ^a  

^a UNITED STATES ARMY MEDICAL RESEARCH INSTITUTE OF INFECTIOUS DISEASES   (United States)

^b HSRF   (United States)

^c CHINESE CENTER FOR DISEASE CONTROL AND PREVENTION   (China)

Author keywords

[No Author keywords available]

Indexed keywords

IMMUNOGLOBULIN F(AB) FRAGMENT; IMMUNOGLOBULIN G1; IMMUNOGLOBULIN G1 ANTIBODY; IMMUNOGLOBULIN HEAVY CHAIN; IMMUNOGLOBULIN LIGHT CHAIN; MONOCLONAL ANTIBODY; RESTRICTION ENDONUCLEASE; UNCLASSIFIED DRUG;

ANIMAL CELL; ANTIBODY ENGINEERING; ANTIGEN ANTIBODY COMPLEX; ANTIGEN SPECIFICITY; ARTICLE; BACULOVIRUS; CASSETTE VECTOR; CELL TRANSFORMATION; CONTROLLED STUDY; ENZYME ACTIVE SITE; ENZYME LINKED IMMUNOSORBENT ASSAY; EXPRESSION VECTOR; GENE CASSETTE; GENE IEI; IMMEDIATE EARLY GENE; IMMUNOPRECIPITATION; IMMUNOTHERAPY; INSECT CELL; MOLECULAR CLONING; NONHUMAN; PRIORITY JOURNAL; PROMOTER REGION; PROTEIN PURIFICATION; PROTEIN STABILITY;

ANIMALIA; INSECTA; UNIDENTIFIED BACULOVIRUS; VECTORS;

EID: 0041941533     PISSN: 15368599     EISSN: None     Source Type: Journal    
DOI: 10.1089/153685903322286548     Document Type: Article

References (41)

1. Levy R: A perspective on monoclonal antibody therapy: where we have been and where we are going. Semin. Hematol. 2000;37:4-6.
2. Sawyer LA: Antibodies for the prevention and treatment of viral diseases. Antiviral Res 2000;47:57-77.
3. Guttieri MC, Bookwalter C, and Schmaljohn C: Expression of a human, neutralizing monoclonal antibody specific to Puumala virus G2-protein in stably-transformed insect cells. J Immunol Methods 2000;246:97-108.
4. Hasemann CA, and Capra JD: Baculovirus expression of complete immunoglobulins in a eukaryotic host. Methods: Companion Methods Enzymol 1991;2:146-158.
5. Horwitz AH, Chang CP, Better M, Hellstrom KE, and Robinson RR: Secretion of functional antibody and Fab fragment from yeast cells. Proc Natl Acad Sci USA 1988;85:8678-8682.
6. Liang M, Guttieri M, Lundkvist A, and Schmaljohn C: Baculovirus expression of a human G2-specific, neutralizing IgG monoclonal antibody to Puumala virus. Virology 1997;235:252-260.
7. Nesbit M, Fu ZF, McDonald-Smith J, Steplewski Z, and Curtis PJ: Production of a functional monoclonal antibody recognizing human colorectal carcinoma cells from a baculovirus expression system. J Immunol Methods 1992;151:201-208.
8. Trill JJ, Shatzman AR, and Ganguly S: Production of monoclonal antibodies in COS and CHO cells. Curr Opin Biotechnol 1995;6:553-560.
9. Wu H, Nie Y, Huse WD, and Watkins JD: Humanization of a murine monoclonal antibody by simultaneous optimization of framework and CDR residues. J Mol Biol 1999;294:151-162.
10. Wells WA: Eek, a XenoMouse: Abgenix, Inc. Chem Biol 2000;7:R185-186.
11. Barbas CF and Lerner RA: Combinatorial immunoglobulin libraries on the surface of phage (Phabs): Rapid selection of antigen-specific Fabs. Methods: Companion Methods Enzymology 1991;2:119-124.
12. Sheets MD, Amersdorfer P, Finnern R, Sargent P, Lindquist E, Schier R, Hemingsen G, Wong C, Gerhart JC, Marks JD, and Lindqvist E: Efficient construction of a large nonimmune phage antibody library: the production of high-affinity human single-chain antibodies to protein antigens. Proc Natl Acad Sci USA 1998;95:6157-6162.
13. Burton DR: Human and mouse monoclonal antibodies by repertoire cloning. Trends Biotechnol 1991;9:169-175.
14. Hoogenboom HR, de Bruine AP, Hufton SE, Hoet RM, Arends JW, and Roovers RC: Antibody phage display technology and its applications. Immunotechnology 1998;4:1-20.
15. Liang M, Chu YK, and Schmaljohn C: Bacterial expression of neutralizing mouse monoclonal antibody Fab fragments to Hantaan virus. Virology 1996;217:262-271.
16. Schmaljohn C, Cui Y, Kerby S, Pennock D, and Spik K: Production and characterization of human monoclonal antibody Fab fragments to vaccinia virus from a phage-display combinatorial library. Virology 1999;258:189-200.
17. Williamson RA, Burioni R, Sanna PP, Partridge LJ, Barbas CF III, and Burton DR: Human monoclonal antibodies against a plethora of viral pathogens from single combinatorial libraries. Proc Natl Acad Sci USA 1993;90:4141-4145.
18. Sharkey RM, Natale A, Goldenberg DM, and Mattes MJ: Rapid blood clearance of immunoglobulin G2a and immunoglobulin G2b in nude mice. Cancer Res 1991;51:3102-3107.
19. Vieira P and Rajewsky K: The half-lives of serum immunoglobulins in adult mice. Eur J Immunol 1988;18:313-316.
20. Bender E, Woof JM, Atkin JD, Barker MD, Bebbington CR, and Burton DR: Recombinant human antibodies: linkage of an Fab fragment from a combinatorial library to an Fc fragment for expression in mammalian cell culture. Human Antibodies Hybridomas 1993;4:74-79.
21. Liang M, Dubel S, Li D, Queitsch I, Li W, and Bautz EKF: Baculovirus expression cassette vectors for rapid production of complete human IgG from phage display selected antibody fragments. J Immunol Methods 2001;247:119-130.
22. Poul MA, Cerutti M, Chaabihi H, Devauchelle G, Kaczorek M, and Lefranc MP: Design of cassette baculovirus vectors for the production of therapeutic antibodies in insect cells. Immunotechnology 1995;1:189-196.
23. Poul MA, Cerutti M, Chaabihi H, Ticchioni M, Deramoudt FX, Bernard A, Devauchelle G, Kaczorek M, and Lefranc MP: Cassette baculovirus vectors for the production of chimeric, humanized, or human antibodies in insect cells. Eur J Immunol 1995;25:2005-2009.
24. Jarvis DL and Summers MD: Glycosylation and secretion of human tissue plasminogen activator in recombinant baculovirus-infected insect cells. Mol Cell Biol 1989;9:214-223.
25. Jarvis DL, Fleming JGW, Kovacs GR, Summers MD, and Guarino LA: Use of early baculovirus promoters for continuous expression and efficient processing of foreign gene products in stably transformed lepidopteran cells. Biotechnology 1990;8:950-955.
26. Jarvis DL, Weinkauf C, and Guarino LA: Immediate-early baculovirus vectors for foreign gene expression in transformed or infected insect cells. Protein Expr Purif 1996;8:191-203.
27. Lee H, Lee P, and Johnson K: Isolation of the etiologic agent of Korean hemorrhagic fever. J Infect Dis 1978;137:298-308.
28. McClain DJ, Harrison S, Yeager CL, Cruz J, Ennis FA, Gibbs P, Wright MS, Summers PL, Arthur JD, and Graham JA: Immunologic responses to vaccinia vaccines administered by different parenteral routes. J Infect Dis 1997;175:756-763.
29. Ruo SL, Sanchez A, Elliot LH, Brammer LS, McCormick JB, and Fisher-Hoch SP: Monoclonal antibodies to three strains of hantaviruses: Hantaan, R22, and Puumala. Arch Virol 1991;119:1-11.
30. Sambrook J, Fritsch EF, and Maniatis T: In: Molecular Cloning: A Laboratory Manual, 2nd ed. Cold Spring Harbor Laboratory Press, New York, 1989.
31. Gustaffson B, Jondal M, and Sundqvist VA: SPAM-8, a mouse-human heteromyeloma fusion partner in production of human monoclonal antibodies. Establishment of a human monoclonal antibody against cytomegalovirus. Human Antibodies and Hybridomas 1991;2:26-32.
32. Lundkvist A, Horling J, Athlin L, Rosen A, and Niklasson B: Neutralizing human monoclonal antibodies against Puumala virus, causative agent of nephropathia epidemica: a novel method using antigen-coated magnetic beads for specific B cell isolation. J Gen Virol 1993;74:1303-1310.
33. Barbas C. III, Kang AS, Lerner RA, and Benkovic SJ: Assembly of combinatorial antibody libraries on phage surfaces: The gene III site. Proc Natl Acad Sci USA 1991;88:7978-7982.
34. Joyce KA, Atkinson AE, Bermudez I, Beadle DJ, and King LA: Synthesis of functional GABAA receptors in stable insect cell lines. FEBS 1993;335:61-64.
35. Summers MD, and Smith GE: A Manual of Methods for Baculovirus Vectors and Insect Cell Culture Procedures Texas Argricultural Experiment Station Bulletin No. 1555, 1987.
36. Schmaljohn C, Hasty S, Harrison S, and Dalrymple J: Characterization of Hantaan virus virons, the prototype virus of hemorrhagic fever with renal syndrome. J Infect Dis 1983;148:1005-1012.
37. Hooper JW, Custer DM, Schmaljohn CS, and Schmaljohn AL: DNA vaccination with vaccinia virus L1R and A33R genes protects mice against a lethal poxvirus challenge. Virology 2000;266:329-339.
38. Persic L, Roberts A, Wilton J, Cattaneo A, Bradbury A, and Hoogenboom H: An integrated vector system for the eukaryotic expression of antibodies or their fragments after selection from phage display libraries. Gene 1997;187:9-18.
39. Boyd PN, Lines AC, and Patel AK: The effect of the removal of sialic acid, galactose, and total carbohydrate on the functional activity of Campath-1H. Mol Immunol 1995;32:1311-1318.
40. zu Putlitz J, Kubasek WL, Duchene M, Marget M, von Specht BU, and Domdey H: Antibody production in baculovirus-lnfected insect cells. Biotechnology 1990;8:651-654.
41. Yokoyama WM. In: Coligan JE, Kruisbeek AM, Margulies DH, and Shevach EM (Eds.). Current Protocols in Immunology. John Wiley and Sons, New York, 1991, p. 2.6.7.